Device Trial Radar · NCT01254929
F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
Last checked: Nov 19, 2026Latest source record: Mar 19, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
299
Actual
Start
Dec 2010
Primary completion
Feb 2014
Study completion Mar 2020
Sponsor
- Lead sponsor
- Seattle Nuclear MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 7, 2010
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare 18F-Fluoride PET bone scans to traditional 99mTc-MDP bone scan to determine if one is better for diagnosing bone metastases.
Conditions
- Cancer
- Bone Metastases
Interventions
F-18 PET bone scanDevice
Following the intravenous administration of approximately 10 mCi F-18, subjects will undergo an F-18 PET bone scan.
Tc-99m bone scanDevice
Following the intravenous administration of approximately 30mCi Tc-99m MDP, subjects will undergo a traditional bone scan on a gamma camera.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Accurate identification of bone metastasesTime frame: Upon study completion (2-3 years)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Seattle Nuclear Medicine
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.